Immunohistochemistry in Gastric Carcinoma: Diagnostic Subtyping, Prognostic Stratification, and Predictive Biomarkers

Authors

  • Anan Fathi Mohamed, Asmaa Hussein Mohamed, Enas Mohamed Fouad, Aisha Elsayed Mohamed Author

DOI:

https://doi.org/10.48047/jmj6cw65

Keywords:

Immunohistochemistry, Gastric Carcinoma, Biomarkers

Abstract

Background: Background: Gastric carcinoma remains a major cause of cancer-related mortality worldwide, largely because many patients present at advanced stage and because the disease comprises biologically diverse tumor entities with different pathways of carcinogenesis and treatment responsiveness. While histomorphology remains the foundation for diagnosis and classification, it does not fully capturethe molecular heterogeneity of gastric cancer or reliably predict prognosis 

Downloads

Download data is not yet available.

References

Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21(11):4012. doi:10.3390/ijms21114012

Lin Y, Zheng Y, Wang HL, Wu J. Global patterns and trends in gastric cancer incidence rates (1988–2012) and predictions to 2030. Gastroenterology. 2021;161(1):116-127. doi:10.1053/j.gastro.2021.03.018

Downloads

Published

2024-11-20

How to Cite

Immunohistochemistry in Gastric Carcinoma: Diagnostic Subtyping, Prognostic Stratification, and Predictive Biomarkers (Anan Fathi Mohamed, Asmaa Hussein Mohamed, Enas Mohamed Fouad, Aisha Elsayed Mohamed , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 6807-6821. https://doi.org/10.48047/jmj6cw65